{"id":616144,"title":"Changes to notification requirements for biologic drugs: Notice to industry - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-02","captureTimestamp":"2026-03-02T17:32:03.968000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/notice-notification-requirements-biologic-drugs.html","snippet":"Changes to notification requirements for biologic drugs: Notice to industry Health Canada is reducing the administrative burden to help clinical trial sponsors and market authorization holders efficiently distribute treatments. On this page Purpose and background Measures to…","rawSnapshotUrl":"/api/snapshots/raw/616144","browseUrl":"https://replay.healtharchive.ca/job-6/20260302173203/https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/notice-notification-requirements-biologic-drugs.html#ha_snapshot=616144","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}